XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 175 filers reported holding XENON PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,080,034 | -16.7% | 500,001 | -6.1% | 3.11% | -22.5% |
| Q2 2023 | $20,508,950 | -30.0% | 532,700 | -34.9% | 4.01% | -30.2% |
| Q1 2023 | $29,294,294 | -12.6% | 818,505 | -3.7% | 5.75% | -12.4% |
| Q4 2022 | $33,515,500 | +9.2% | 850,000 | 0.0% | 6.57% | -11.1% |
| Q3 2022 | $30,685,000 | -8.7% | 850,000 | -23.0% | 7.39% | -8.3% |
| Q2 2022 | $33,594,000 | +19.4% | 1,104,334 | +20.0% | 8.06% | +18.5% |
| Q1 2022 | $28,124,000 | -5.2% | 920,000 | -3.2% | 6.80% | +3.1% |
| Q4 2021 | $29,678,000 | +177.5% | 950,000 | +35.7% | 6.59% | +164.8% |
| Q3 2021 | $10,696,000 | – | 700,000 | – | 2.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 266,961 | $10,277,999 | 12.45% |
| COMMODORE CAPITAL LP | 1,845,000 | $71,032,500 | 7.98% |
| Altium Capital Management LP | 228,000 | $8,778,000 | 6.64% |
| TLS Advisors LLC | 33,756 | $1,300 | 5.58% |
| GREAT POINT PARTNERS LLC | 530,000 | $20,405,000 | 3.99% |
| DAFNA Capital Management LLC | 280,538 | $10,800,713 | 2.95% |
| Paradigm Biocapital Advisors LP | 989,327 | $38,089,090 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $4,403,630 | 2.81% |
| Avoro Capital Advisors LLC | 4,900,000 | $188,650,000 | 2.56% |
| Ghost Tree Capital, LLC | 185,000 | $7,122,500 | 2.35% |